NMR metabolic profiling of follicular fluid for investigating the different causes of female infertility: a pilot study.
Adult
Endometriosis
/ metabolism
Female
Fertilization in Vitro
/ methods
Follicular Fluid
/ cytology
Humans
Infertility, Female
/ etiology
Magnetic Resonance Imaging
/ methods
Magnetic Resonance Spectroscopy
/ methods
Metabolome
/ physiology
Metabolomics
/ methods
Oocytes
/ metabolism
Ovulation Induction
/ methods
Pilot Projects
Polycystic Ovary Syndrome
/ metabolism
Pregnancy
Follicular fluid
Gynaecological pathologies
In vitro fertilization (IVF)
Infertility factors
Metabolomics
NMR spectroscopy
Journal
Metabolomics : Official journal of the Metabolomic Society
ISSN: 1573-3890
Titre abrégé: Metabolomics
Pays: United States
ID NLM: 101274889
Informations de publication
Date de publication:
29 01 2019
29 01 2019
Historique:
received:
03
07
2018
accepted:
21
01
2019
entrez:
5
3
2019
pubmed:
5
3
2019
medline:
24
3
2020
Statut:
epublish
Résumé
Several metabolomics studies have correlated follicular fluid (FF) metabolite composition with oocyte competence to fertilization, embryo development and pregnancy but there is a scarcity of research examining the metabolic effects of various gynaecological diseases. In this study we aimed to analyze and correlate the metabolic profile of FF from women who were following in vitro fertilization (IVF) treatments with their different infertility pathologies. We selected 53 women undergoing IVF who were affected by: tubal diseases, unexplained infertility, endometriosis, polycystic ovary syndrome (PCOS). FF of the study participants was collected at the time of oocytes retrieval. Metabolomic analysis of FF was performed by nuclear magnetic resonance (NMR) spectroscopy. FF presents some significant differences in various infertility pathologies. Although it was not possible to discriminate between FF of control participants and women with tubal diseases and unexplained infertility, comparison of FF metabolic profile from control women with patients with endometriosis and PCOS revealed significant differences in some metabolites that can be correlated to the causes of infertility. NMR-based metabolic profiling may be successfully applied to find diagnostic biomarkers for PCOS and endometriosis and it might be also used to predict oocyte developmental potential and subsequent outcome.
Identifiants
pubmed: 30830455
doi: 10.1007/s11306-019-1481-x
pii: 10.1007/s11306-019-1481-x
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
19Références
Gynecol Obstet Fertil. 2010 Jun;38(6):402-4
pubmed: 20576551
Syst Biol Reprod Med. 2019 Feb;65(1):39-47
pubmed: 29806498
J Assist Reprod Genet. 2014 Feb;31(2):205-11
pubmed: 24337962
Expert Rev Mol Diagn. 2008 Sep;8(5):617-33
pubmed: 18785810
Trends Endocrinol Metab. 2017 Mar;28(3):186-198
pubmed: 27988256
Nat Protoc. 2007;2(11):2692-703
pubmed: 18007604
Reprod Biol Endocrinol. 2009 May 04;7:40
pubmed: 19413899
Reprod Biomed Online. 2004 Jun;8(6):644-8
pubmed: 15169578
Metabolomics. 2015;11(4):872-894
pubmed: 26109927
Reproduction. 2013 Aug 21;146(4):389-95
pubmed: 23886995
Biomed Res Int. 2015;2015:130854
pubmed: 26240814
MAGMA. 2013 Apr;26(2):193-202
pubmed: 22878530
Endocr Rev. 2015 Oct;36(5):487-525
pubmed: 26426951
J Assist Reprod Genet. 2015 Dec;32(12):1817-25
pubmed: 26497128
Reprod Biomed Online. 2012 Jun;24(6):591-602
pubmed: 22503948
Int J Clin Exp Pathol. 2014 Sep 15;7(10):7220-9
pubmed: 25400819
Hum Reprod Update. 2017 Nov 1;23(6):723-736
pubmed: 29069503
Int J Reprod Med. 2013;2013:603167
pubmed: 25763388
Mol Biosyst. 2017 Jun 1;13(6):1213-1222
pubmed: 28475193
Hum Reprod. 1999 Jan;14(1):167-71
pubmed: 10374115
Fertil Steril. 2017 Mar;107(3):523-532
pubmed: 28189296
Diabetes. 2013 Jul;62(7):2278-86
pubmed: 23493574
Fertil Steril. 2017 Oct;108(4):667-672.e5
pubmed: 28874260
Arch Toxicol. 2011 Jan;85(1):5-17
pubmed: 20953584
Fertil Steril. 2012 Dec;98(6):1449-57.e6
pubmed: 22921074
Free Radic Biol Med. 2015 Sep;86:295-307
pubmed: 26057937
Hormones (Athens). 2015 Apr-Jun;14(2):190-200
pubmed: 26158651
Placenta. 2011 Sep;32 Suppl 3:S257-63
pubmed: 21703683
Clin Chim Acta. 2014 Feb 15;429:181-8
pubmed: 24368231
Obstet Gynecol Clin North Am. 2012 Dec;39(4):551-66
pubmed: 23182560
J Assist Reprod Genet. 2018 Nov;35(11):2063-2070
pubmed: 30069850
Hum Reprod. 2014 Nov;29(11):2413-20
pubmed: 25256566
Curr Opin Biotechnol. 2017 Feb;43:34-40
pubmed: 27580257
Mol Biosyst. 2012 Oct 30;8(12):3281-7
pubmed: 23079773
N Engl J Med. 2009 Jan 15;360(3):268-79
pubmed: 19144942
Trends Mol Med. 2003 May;9(5):223-8
pubmed: 12763528
Med Hypotheses. 2012 Apr;78(4):475-8
pubmed: 22336088
Hum Reprod Update. 2010 Nov-Dec;16(6):651-74
pubmed: 20462942
Oncotarget. 2017 Jul 6;8(46):80472-80480
pubmed: 29113318
Fertil Steril. 1985 Mar;43(3):351-2
pubmed: 3979573
NMR Biomed. 2010 Jun;23(5):485-95
pubmed: 20336675
Theriogenology. 2007 Sep 1;68 Suppl 1:S56-62
pubmed: 17490741
Front Physiol. 2016 Apr 05;7:124
pubmed: 27092084
J Ovarian Res. 2013 Feb 06;6(1):11
pubmed: 23388048
Mol Biosyst. 2016 Oct 18;12(11):3407-3416
pubmed: 27714060
Fertil Steril. 2012 May;97(5):1078-84.e1-8
pubmed: 22365382